Mutations in POFUT1, Encoding Protein O-fucosyltransferase 1, Cause Generalized Dowling-Degos Disease  by Li, Ming et al.
ARTICLE
Mutations in POFUT1, Encoding
Protein O-fucosyltransferase 1, Cause
Generalized Dowling-Degos Disease
Ming Li,1 Ruhong Cheng,1 Jianying Liang,1 Heng Yan,2 Hui Zhang,1 Lijia Yang,3 Chengrang Li,4
Qingqing Jiao,1 Zhiyong Lu,1 Jianhui He,5 Jin Ji,3 Zhu Shen,2 Chunqi Li,5 Fei Hao,2 Hong Yu,1,*
and Zhirong Yao1,*
Dowling-Degos disease (DDD), or reticular pigmented anomaly of the flexures, is a type of rare autosomal-dominant genodermatosis
characterized by reticular hyperpigmentation and hypopigmentation of the flexures, such as the neck, axilla, and areas below the breasts
and groin, and shows considerable heterogeneity. Loss-of-function mutations of keratin 5 (KRT5) have been identified in DDD individ-
uals. In this study, we collected DNA samples from a large Chinese family affected by generalized DDD and found nomutation of KRT5.
We performed a genome-wide linkage analysis of this family andmapped generalized DDD to a region between rs1293713 and rs244123
on chromosome 20. By exome sequencing, we identified nonsense mutation c.430G>T (p.Glu144*) in POFUT1, which encodes protein
O-fucosyltransferase 1, in the family. Study of an additional generalized DDD individual revealed the heterozygous deletion mutation
c.482delA (p.Lys161Serfs*42) in POFUT1. Knockdown of POFUT1 reduces the expression of NOTCH1, NOTCH2, HES1, and KRT5 in
HaCaTcells. Using zebrafish, we showed that pofut1 is expressed in the skin and other organs. Morpholino knockdown of pofut1 in zebra-
fish produced a phenotype characteristic of hypopigmentation at 48 hr postfertilization (hpf) and abnormal melanin distribution at 72
hpf, replicating the clinical phenotype observed in our DDD individuals. At 48 and 72 hpf, tyrosinase activities decreased by 33% and
45%, respectively, and melanin protein contents decreased by 20% and 25%, respectively. Our findings demonstrate that POFUT1
mutations cause generalized DDD. These results strongly suggest that the protein product of POFUT1 plays a significant and conserved
role in melanin synthesis and transport.Introduction
Dowling-Degos disease (DDD [MIM 179850]) is an auto-
somal-dominant genodermatosis characterized by reticular
pigmented anomaly. It was first described by Dowling and
Freudenthal in 1938.1 Degos and Ossipowski confirmed
this disease to be a distinct clinical entity in 1954.2 In
classic DDD, individuals usually present with pigmenta-
tion with a flexural distribution.3,4 However, generalized
DDD could also manifest numerous hypopigmented or
erythematous macules and papules on the neck, chest,
and abdomen.5–9 Generalized DDD resembles dyschroma-
tosis universalis hereditaria (DUH [MIM 127500]).10 In
contrast to those of DUH and dyschromatosis symmetrica
hereditaria (MIM 127400), the histopathology of DDD
reveals typical thin branch-like patterns of epidermal
downgrowth.9–11
In 2006, Li et al. mapped the DDD-associated gene to
chromosomal region 17p13.3.3 Betz et al. mapped a novel
locus for DDD to chromosome 12q in twoGerman families
and identified loss-of-function mutations in keratin 5
(KRT5 [MIM 148040]).4 However, no KRT5 mutations
have been identified in several familial and sporadic
cases.4 Therefore, additional genetic mutations responsible
for this disease should be investigated.1Department of Dermatology, Xinhua Hospital, Shanghai Jiaotong University S
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ilies affected by DDD and identified two mutations in pro-
tein O-fucosyltransferase 1 (POFUT1 [MIM 607491]) as the
cause of the disease. Functional analysis revealed the role
of POFUT1 in melanin synthesis and transport.Material and Methods
Subjects and Clinical Presentation
This study investigated two Chinese generalized-DDD-affected
families, one from Jiangsu Province and one from Chongqing.
Family 1 includes 25 individuals (13 affected and 12 unaffected),
and family 2 includes seven individuals (two affected and five
unaffected) (Figures 1A and 1B). DDD was diagnosed by experi-
enced dermatologists on the basis of typical manifestations and
histopathological findings. After informed consent was obtained,
genomic DNA was extracted from the peripheral-blood lympho-
cytes of DDD individuals. Skin biopsies were performed on the
groin of the index individual (III:11) in family 1 and on the
neck of the proband (II:3) in family 2. This study was approved
by the ethics committees of the Shanghai Jiaotong University
School of Medicine and was conducted in accordance with the
principles of the Declaration of Helsinki.
The proband of family 1 is a 49-year-old woman with a 20-year
history of reticular hyperpigmentation on the skin of the neck,
wrist, chest, inguinal regions, and inner sides of the thighs (Figureschool of Medicine, Shanghai 200092, China; 2Department of Dermatology,
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Figure 1. Family Pedigrees and Clinical Photographs of
Individuals with Generalized DDD
(A and B) Pedigrees of families 1 (A) and 2 (B). The squares and cir-
cles denote males and females, respectively. Affected individuals
are shown in black. The probands are denoted by arrows.
(C–F) Clinical photographs of individual III:11 in family 1. Retic-
ular hyperpigmentation on the wrists (C) and inguinal regions
(D), reticular hyperpigmentation and hyperkeratotic dark-brown
papules on the neck (E), and reticular hypopigmentation on the
abdomen (F) are shown.
(G–J) Clinical photographs of individual II:3 in family 2. Reticular
hyperpigmentation and hypopigmentation on the bilateral axillae
with hyperkeratotic dark-brown papules (G and H), reticular
hyperpigmentation and hypopigmentation on the neck (I), and
reticular hypopigmentation on the abdomen (J) are shown.1C–1E). Spots of pigmentation were initially found on the neck at
the age of 23 years. These spots gradually developed in number
and size and showed deeper coloration. Hypopigmented macules
appeared on the abdomen and back 20 years ago without obvious896 The American Journal of Human Genetics 92, 895–903, June 6, 2subjective symptoms (Figure 1F). Skin lesions obviously worsened
in summer and lightened in winter. All DDD individuals presented
with pigmentation on the skin of the neck, wrist, chest, inguinal
regions, and inner sides of the thighs (Figure S1, available online).
Hypopigmented macules and hyperkeratotic darkbrown papules
were found on the neck, chest, and back of some DDD individuals
in family 1 (Figure S1). Hematoxylin and eosin staining showed
hyperkeratosis with multiple horny follicular plugs and papillary
epidermal downgrowth with abnormal basal pigment-granule dis-
tribution. Sporadicmelanin granules andmelanophages were seen
in the superficial layer of dermis (Figure S2A). Masson-Fontana
stain showed uneven distribution of melanin in the epidermis. A
region of stratum basal showed a large number of melanin parti-
cles that were evenly distributed all over the layer of the epidermis
(Figure S2C). Another region of the epidermis, however, rarely
showed positive staining (Figure S2D).
Transmission electron microscopy (TEM) showed that melano-
cytes in the controls contained sufficient melanosomes at stages
I–IV in the cytoplasm. By contrast, all of melanocytes of DDD
individual III:11 in family 1 were small in size and lacked mela-
nosomes (Figures 2A–2C). In addition, premelanosomes were
notably rarely seen in melanocytes scattered with melanosomes
(Figure 2A). Nevertheless, keratinocytes showed normal keratin fil-
aments and interactions with hemidesmosomes and desmosomes
(Figure 2D).
In family 2, the proband is a 53-year-old woman who has pre-
sented with brown macules over flexural areas for over 32 years.
Skin lesions initially developed on the neck and gradually
increased in size. Pigmented and hypopigmented macules then
spread to the face, bilateral axillae, popliteal fossa, and groin
without subjective symptoms (Figures 1G–1J). Some of the mac-
ules merged and organized in a reticular pattern. Hyperkeratotic
dark-brown papules were found on the bilateral axillae (Figures
1G and 1H). A skin biopsy from the neck showed epidermal papil-
lomatous hyperkeratosis with keratotic plugs, trochanterellus
elongation with abnormal basal pigment-granule distribution,
and perivascular lymphohistiocytic infiltration of the superficial
dermis (Figure S2B).Sequence Analysis
Five micrograms of genomic DNA from an affected individual
(III:8 in family 1) were sent to Genergy Biotech (Shanghai, China)
for whole-exome capture and sequencing. A Sure Select HumanAll
Exon Kit (Agilent) was used for exon capture. Exomes were then
sequenced on an Illumina Hiseq2000 (Illumina) according to
the manufacturer’s instructions. Variants were filtered against
dbSNP135, the 1000 Genomes Project, and HapMap 8.
We designed primers flanking all seven coding exons and
intron-exon boundaries of POFUT1 (RefSeq accession number
NM_015352.1) (Table S1). PCR products were purified with a
QIAquick PCR Purification Kit (QIAGEN). POFUT1 was sequenced
with an ABI PRISM 3730 automated sequencer (Applied Bio-
systems). Sequence comparisons and analysis were performed
with Phred-Phrap-Consed program version 12.0. Samples from
600 unrelated population-matched controls were sequenced for
exclusion of the possibility that the mutation identified was a
polymorphism in POFUT1.Zebrafish Studies
The wild-type AB strain of zebrafish was used in this study. Zebra-
fish embryos were generated by natural pairwise mating in our013
Figure 2. Electron Microscopy of Skin
from DDD Individual III:11 in Family 1
and a Control
(A) Ultrathin section from the individual
with DDD shows a few melanosomes in
the melanocytes. Of note, premelano-
somes are rarely seen. Abbreviations are as
follows: M, melanocyte; K, keratinocyte;
and N, nucleus.
(B and C) In contrast with control skin (C),
the melanocyte of the individual with
DDD (B) is small in size, has lighter cyto-
plasm, and lacks melanosomes.
(D) Normal keratin filaments and their
interaction with hemidesmosomes and
desmosomes of the individual with DDD.aquaculture facility. All zebrafish studies were conducted under
the guidance and approval of the institutional animal care and
use committees at Shanghai Jiaotong University School of Medi-
cine and Wenzhou Medical College.
The sequence of the exon 2-intron 2 splice pofut1 morpho-
lino (pofut1-MO) was 50-GACGTGTTGTTGTGTTTACATTAGC-30,
and the sequence for the standard control morpholino (scMO)
was 50-CCTCTTACCTCAGTTACAATTTATA-30 (Gene Tools).
Approximately 4 nl of 0.25 mM pofut1 or the scMO solution
was microinjected into zebrafish embryos at the 1- to 2-cell
stage with a microinjector (NARISHIGE IM-300) under a stereo
microscope (Olympus SZX7). Zebrafish embryos of controls
and pofut1 morphants were allowed to develop until 72 hr post-
fertilization (hpf) for the evaluation of melanin formation and
distribution.
Primers spanning pofut1 exon 1 (forward primer: 50-CAGACGT
GACGTGGGATG-30) and exon 6 (reverse primer: 50-CTGTGGA
GACGCCATAAAG-30) were used for RT-PCR analysis for confirma-
tion of the effectiveness of gene knockdown. The predicted size of
the amplified cDNA fragment containing exon 2was 722 bp, and a
product generated from cDNA without part of exon 2 was esti-
mated to be about 617 bp in size. The primer ef1a sequences
used as the internal control were 50-TCACCCTGGGAGTGAAA
CAGC-30 (forward) and 50-ACTTGCAGGCGATGTGAGCAG-30
(reverse). All of the primers used for RT-PCR analysis were pur-
chased from Invitrogen.
Zebrafish were photographed at 48 and 72 hpf under a stereo
microscope (Olympus SZX7) coupled with a charge-coupled
device (JVC) for obtaining quantitative information on melanin
contents; changes in body length among different groups were
analyzed with Image J software (National Institutes of Health).
Approximately 30–40 zebrafish per group were used for body-
length analysis.
Tyrosinase activity and melanin content were determined by a
microplate reader (Mithras LB940, Berthold Technologies) as
described previously with minor modifications.12 All experiments
were repeated at least three times, and four to five samples were
used per group.
Fifty embryos per sample were collected at 6, 12, 24, 28, 32, 48,
60, and 72 hpf for RT-PCR assessment of the time course of pofut1
expression. Primers used included forward primer 50-CAGACGT
GACGTGGGATG-30 and reverse primer 50-CTGTGGAGACGCCA
TAAAG-30.The AmCell-Culture Studies
HaCaT human keratinocyte cells were cultured at 37C in a
humidified 5% CO2 atmosphere in RPMI-1640 medium with
10% fetal calf serum (GIBCO, Invitrogen), 100 IU/ml penicillin
G, and 100 mg/ml streptomycin sulfate (Sigma-Aldrich).
POFUT1 lentivirus expression vector pLV.Ex3d.P/puro-Pofut1
was constructed by replacement of the GFP fragment of the
pLV.Ex3d.P/puro vector (Cyagen) with the POFUT1 (RefSeq
NM_015352.1) coding sequence amplified from the plasmid. Oli-
gonucleotides were synthesized for the generation of an annealing
shRNA targeting the sequence of POFUT1 from positions 249–269
(50-CCATGTGTCCTACCAGAAGTA-30) and from positions 462–
482 (50-GTTTCATGTGAGTTTCAACAA-30). The fragments were
cloned separately into pLentiX1/puro (Cyagen).
Virus packaging was performed in human embryonic kidney
(HEK) 293T cells after the cotransfection of pLV.Ex3d.P/puro-
Pofut1 or pLentiX1/puro-shRNA-Pofut1 with the packaging
plasmid (pLV/helper-SL3, pLV/helper-SL4, and pLV/helper-SL5)
with the use of Lipofectamine 2000 (Invitrogen). Viruses were har-
vested 48 hr after transfection. HaCaT cells were infected with the
filtered lentivirus in the presence of 6 mg/ml polybrene (Sigma-
Aldrich). The knockdown efficiency was detected at the mRNA
level by quantitative real-time PCR.Quantitative Real-Time PCR Analysis
We used quantitative real-time PCR to determine the expression
levels of pofut1 transcripts in adult zebrafish tissues or organs,
including the eye, brain, skin, liver, heart, spleen, fin, trunkmuscle,
testis, andovary.Wealsoappliedquantitative real-timePCRtoquan-
tify the relative mRNA expressions of pofut1, notch1, notch2, hey1,
krt5, mitf, and tyr in 48 and 72 hpf embryos. The PCR primers are
given inTable S2.WeusedTRIzol reagent (Invitrogen) to isolate total
RNAfromthe samples.WepreparedcDNAfrom1mgof totalRNAper
group by using RT-PCR kits (Toyobo) at a final volume of 20 ml.
Wecarriedout eachPCRdetermination in triplicate at afinalvolume
of 25 ml by using SYBR Premix Ex Taq Green PCR Mix (Takara)
in a Light Cycler 480 real-time PCRmachine (Roche Diagnostics).
We used the same techniques to determine the expression levels
of POFUT1 in keratinocytes, HaCaT cells, melanocytes, and
normal human skin.
To analyze mRNA changes in response to treatments, we used
TRIzol reagent to extract total cellular RNA. The expression levelserican Journal of Human Genetics 92, 895–903, June 6, 2013 897
of POFUT1, NOTCH1 (MIM 190198), NOTCH2 (MIM 600275),
HES1 (MIM 139605), and KRT5 (MIM 148040) transcripts were
examined in HaCaT cells. The PCR primers are given in Table S3.
Statistical Analysis
We performed a one-way ANOVA to determine statistical signifi-
cance and a Dunnett’s post hoc test to independently compare
the treatment group with the control groups (SPSS). p < 0.05
was considered statistically significant. All of the data are pre-
sented as the mean5 SD unless otherwise stated.Results
Linkage of DDD to Chromosome 20
In order to identify the candidate gene for generalized
DDD, we genotyped 14 individuals from family 1 (II:2,
III:2, III:3, III:4, III:6, III:7, III:8, III:10, III:11, III:12, IV:1,
IV:2, IV:5, and IV:6) by using an Illumina Infinium
HumanLinkage-24 panel after excluding pathogenic
KRT5 mutations in the family 1 proband by conventional
Sanger sequencing. Genome-wide linkage analysis was
performed with a total of 5,913 SNP markers within
average genetic and physical distances of 441 kb and
0.58 cM, respectively. SNPs with a call rate less than
90%, monomorphic SNPs, and non-Mendelian trans-
mitted markers were removed. A total of 4,456 informative
autosomal SNPs were retained in the linkage analysis.
Multipoint parametric linkage analyses were performed
with the MERLIN program version 1.1.2. A fully penetrant
autosomal-dominant model was used with a rare disease
frequency of 0.0001. Critical recombination events of
the pedigree members were also determined through
haplotype construction in MERLIN.
Genome-wide linkage analysis in family 1 revealed mul-
tipoint LOD scores > 3 for chromosome 20, indicating
linkages to this chromosome (Figures 3A and 3B and Table
S4). No other locus of suggestive linkage was detected.
Recombination events were observed in individuals III:3,
IV:1, and IV:5 (Figure 3A). These recombination events
defined the susceptibility region in 20p11.21–20q13.12
to a 14.79 cM interval (54.04–68.83 cM between
rs1293713 and rs244123). All affected individuals shared
a common haplotype across this disease interval. The sug-
gested haplotypes of this pedigree are shown in Figure 3A.
POFUT1 Mutations
The map region contained 253 known genes. We then
sequenced the entire exome in one affected member
(III:8) of family 1. Exome sequencing generated
81,327,908 unique reads. The mean read depth across
the exome was 71 reads. A total of 143,919 variants were
identified in this DDD individual. After the identified
heterozygous variants were filtered through the 1000
Genomes Project, HapMap 8, and dbSNP135, two variants
remained in the 14.79 cM critical region. These remain-
ing variants included missense mutation c.329G>A
(p. Cys110Tyr) in exon 3 of CST7 (MIM 603253; RefSeq898 The American Journal of Human Genetics 92, 895–903, June 6, 2NM_003650.3) and nonsense mutation c.430G>T
(p.Glu144*) in exon 4 of POFUT1. The nonsense mutation
was confirmed by conventional sequencing and cosegre-
gated with generalized DDD in family 1 (Figure 3C) and
was absent in 600 healthy unrelated Chinese individuals.
The nonsense mutation was present in all affected mem-
bers and absent in all unaffected family members within
family 1. The missense mutation in CST7 did not cosegre-
gate within the family. The affected members (III:3, IV:1,
and IV:2) were not found to harbor this mutation.
To confirm whether POFUT1 is also mutated in an addi-
tional individual affected by generalized DDD, we screened
POFUT1 coding sequence by Sanger sequencing in a 53-
year-old woman from family 2 (from Chongqing, China).
Deletion of an adenine (c.482delA [p.Lys161Serfs*42])
was identified in exon 4 of POFUT1 in this DDD individual;
this deletion was also absent in unaffected family members
(II:1 and II:4) in family 2 and 600 healthy unrelated
Chinese individuals (Figure 3D).
To determine whether the mutant allele is present in the
RNA of affected individuals, we isolated RNA from immor-
talized lymphocytes of two affected individuals (III:8 and
IV:2) and a normal member (IV:3) from family 1. After
cDNA synthesis and PCR with gene-specific primers, we
sequenced the obtained products. In the two affected indi-
viduals, normal transcripts were detected but the truncated
POFUT1 transcripts were not detected, presumably because
of nonsense-mediated decay (Figure 3E). We could not
obtain a POFUT1 transcript from the DDD individual in
family 2.
POFUT1 in Skin Biopsies of Affected Individuals
We also examined the localization patterns of POFUT1 in
individual III:11 in family 1 by using rabbit polyclonal
antibodies against POFUT1 (ab140205, Abcam). Immuno-
histochemical staining showed nonuniform localization of
POFUT1 in the epidermis. Themajority of the cells showed
weak cytoplasmic staining, but local keratinocytes showed
relatively stronger staining. In general, POFUT1 localiza-
tion obviously decreased in the DDD individual compared
with the control (Figures S2E–S2G).
Analysis of Pofut1 Knockdown in Zebrafish
Pofut1 was successfully knocked down in zebrafish
embryos injected with pofut1-MO (termed the pofut1-MO
group) as compared with zebrafish embryos injected with
scMO (termed the scMO group) and untreated control
groups, although no changes in ef1a expression were
observed among the groups. Either no mRNA transcripts
or two mRNA transcripts emerged in the pofut1-MO group
from 12 to 72 hpf, whereas no differences were observed
between the scMO and untreated control groups
(Figure 4A). We screened pofut1 coding sequence by Sanger
sequencing and identified the 105 bp deletion in exon 2 in
the pofut1-MO group (Figure 4B).
The melanin contents in the zebrafish tail at 48 hpf
(Figure 4C) and both the tail and body axis at 72 hpf013
Figure 3. Identification of the Disease-
Causing POFUT1 Mutations in Two
Families Affected by Generalized DDD
(A) Haplotype analysis of family 1. Haplo-
type indicates heterozygosity between
rs1293713 and rs244123 in affected
family members. The recombination
events defined the susceptibility region in
20p11.21–20q13.12 to a 14.79 cM interval.
Red bars indicate the chromosomal region
sharedbyaffectedmembers of thepedigree.
(B) Output of the multipoint-LOD-score
analysis for chromosome 20.
(C and D) POFUT1 mutations in the two
families: c.430G>T (p.Glu144*) in family
1 (C) and c.482delA (p.Lys161Serfs*42) in
family 2 (D). The black arrows indicate
mutations.
(E) The normal POFUT1 transcripts from
the DDD individual and control skin.(Figure 4D) decreased significantly in the pofut1-MO group
compared with the scMO and untreated control groups. In
addition, the melanin distribution in the zebrafish tail pre-
sented as dispersion in the pofut1-MO group at 72 hpf
(Figure 4D). Zebrafish body lengths shortened significantly
in the pofut1-MO group compared with the scMO and
untreated control groups (data not shown).The American Journal of HumaAt 48 and 72 hpf in the pofut1-MO
group, tyrosinase activities decreased
by 33% and 45%, respectively,
whereas melanin protein contents
decreased by 20% and 25%, respec-
tively (Figure 4E).
The time course of pofut1 expres-
sion revealed that pofut1 transcripts
were detectable at all designated
time points from 6 to 72 hpf and
that there was dramatically increased
expression beginning at 32 hpf.
Pofut1 was successfully knocked
down in the entire pofut1-MO group
from 12 to 72 hpf (Figure 4F).
We also applied quantitative real-
time PCR to quantify the relative
mRNA expressions of pofut1, notch1,
notch2, hey1, krt5, mitf, and tyr at 48
and 72 hpf embryos. Morpholino
knockdown of pofut1 in zebrafish
resulted in a corresponding decrease
in the expression levels of pofut1,
notch2, hey1, krt5, mitf, and tyr. The
expression of notch1 decreased at 48
hpf but did not show significant
change between the pofut1-MO
group and the controls at 72 hpf
(Figures 5A and 5B).
Pofut1 expression levels of tran-
scripts were higher in the testisthan in other tissues or organs in adult zebrafish
(Figure S3).
Consequences of Reduced POFUT1 in Human Cells
To investigate whether POFUT1 is expressed in the skin, we
examined POFUT1 expression in different human cell lines
by using quantitative real-time PCR. POFUT1 expressionn Genetics 92, 895–903, June 6, 2013 899
Figure 4. Identification of the Effectiveness of pofut1 Knockdown and the Effect of Tyrosinase Activity andMelanin Protein Contents
of Zebrafish by Knockdown of Pofut1 Expression
(A and B) Effectiveness of pofut1 knockdown was confirmed by RT-PCR and Sanger sequencing. The expression of pofut1 decreased obvi-
ously in 72 hpf (A), and compared to the wild-type cDNA sequence, the cDNA sequence of the pofut1-MO group showed a lack of 105 bp
from exon 2 (B). MO* indicates the pofut1-MO group.
(C and D) Zebrafish phenotype observation at 48 and 72 hpf. The melanin contents in the zebrafish tail at 48 hpf (C) and in both the tail
and body axis at 72 hpf (D) decreased significantly in the pofut1-MO group compared with controls, and the melanin distribution in the
zebrafish tail was presented as dispersion in the pofut1-MO group (D). The black arrow indicates abnormal melanin distribution in the
zebrafish fin.
(E) Detection of tyrosinase activity and melanin protein contents at 48 and 72 hpf. Both tyrosinase activity and melanin protein con-
tents were lower in the pofut1-MO group at 48 and 72 hpf, respectively, than in controls. The results are shown as themean5 SD (n¼ 5),
and similar results were obtained when the experiments and measurements were repeated three times. Error bars indicate the mean5
SD. ***p < 0.001, **p < 0.01, *p < 0.05.
(F) RT-PCR analyses of pofut1 expression in zebrafish from 6 to 72 hpf. Pofut1 was knocked down in all pofut1-MO groups from 12 to
72 hpf. The size of the amplified cDNA fragment containing exon 2 was 722 bp, and a product generated from cDNA without part of
exon 2 of the pofut1-MO group was 617 bp in size.was much higher in melanocytes than in other cell lines
and normal skin (Figure S4).
The shRNA POFUT1 knockdown efficiency was detected
by quantitative real-time PCR in HaCaT cells. The results
indicated that the knockdown efficiency of the two frag-
ments described above was 34.8% (50-CCATGTGTCCTAC
CAGAAGTA-30) and 95.4% (50-GTTTCATGTGAGTTTCAA
CAA-30). The higher efficiency of shRNA knockdown
of POFUT1 in HaCaT cells resulted in a corresponding
decrease in the expression of POFUT1, NOTCH1, NOTCH2,
HES1, and KRT5 (Figure 5C).900 The American Journal of Human Genetics 92, 895–903, June 6, 2Discussion
The Notch signaling pathway is a conserved signaling
pathway that plays an important role in cell fate and tis-
sue formation during embryogenesis.13 There are four
Notch receptors (NOTCH1–NOTCH4) and five Notch
ligands (JAG1, JAG2, DLL1, DLL3, and DLL4) in this
signaling pathway in mammals.14 Notch receptors are
transmembrane glycoproteins. About 29–36 epidermal
growth factor (EGF)-like repeats contain a consensus
sequence for O-fucosylation in their extracellular013
Figure 5. Analysis of Pofut1 Knockdown in Zebrafish and Reduced POFUT1 in HaCaT Cells
(A and B) RNA expression levels of pofut1, notch1, notch2, hey1, krt5, tyr, and mitf were determined by quantitative real-time PCR at 48
and 72 hpf in zebrafish. Morpholino knockdown of pofut1 in zebrafish resulted in a corresponding decrease in the expression of pofut1,
notch2, hey1, krt5, tyr, and mitf at 48 (A) and 72 (B) hpf. The expression of notch1 decreased at 48 hpf, but not at 72 hpf. The results
are shown as the mean 5 SD (n ¼ 3); one representative experiment of two is shown. Error bars indicate the mean 5 SD. **p <
0.01, *p < 0.05.
(C) RNA expression levels of POFUT1, NOTCH1, NOTCH2, HES1, and KRT5 were determined by quantitative real-time PCR in HaCaT
cells. The shRNA knockdown of POFUT1 in HaCaT cells resulted in a corresponding decrease in the expression of POFUT1, NOTCH1,
NOTCH2, HES1, and KRT5. The results are shown as the mean 5 SD (n ¼ 3); one representative experiment of two is shown. Error
bars indicate the mean5 SD. ***p < 0.001, **p < 0.01, *p < 0.05.domain.15 POFUT1 adds O-linked fucose to EGF-like
repeats of Notch receptors, after which Notch ligands
bind to Notch receptors and induce the proteolytic release
of Notch intracellular domain (NICD).14,15 NICD, in a
complex with the transcriptional repressor RBP-J, activates
target genes, such as HES1. Therefore, POFUT1 is an essen-
tial component of the canonical Notch signaling
pathway.15 In order to validate the impact of POFUT1
loss of function on the Notch signaling pathway, we
detected the expression of receptor-encoding genes
NOTCH1 (MIM 190198) and NOTCH2 (MIM 600275)
and the target gene, HES1, in the Notch pathway in
shRNA POFUT1 in HaCaT cells. The expression levels of
NOTCH1, NOTCH2, and HES1 were all downregulated.
The same result was again demonstrated in the pofut1-
MO group, indicating that loss of function of POFUT1
has a strong impact on the Notch pathway.
Aberrant gain or loss of function of Notch signaling
components has been connected to several inherited
human diseases since 1991.16–26 Mutations in NOTCH1
cause several types of cardiac disease and cutaneous
and lung squamous cell carcinoma, whereas mutations
in NOTCH2 and NOTCH3 (MIM 600276) cause Hajdu-
Cheney syndrome (MIM 102500) and adult-onset cerebral
autosomal-dominant arteriopathy with subcortical in-
farcts and leukoencephalopathy (MIM 125310), respec-
tively.16–20 Mutations in the ligand-encoding delta-like-3
(DLL3 [602768]) cause autosomal-recessive spondylocostal
dysostosis.25 Alagille syndrome type 1 (MIM 118450) is
caused by mutations in JAG1 (MIM 601920) and
NOTCH2.27,28 In 2012, Hassed et al. reported that muta-
tions in RBPJ (MIM 147183) cause Adams-Oliver syndrome
(MIM 100300).29 Abrogation of Pofut1 in mice causes em-
bryonic lethality with Notch-like phenotypes, including
vasculogenic, cardiogenic, and neurogenic phenotypes.30
In this study, nonsense mutation c.430G>T (p.Glu144*)
was detected in exon 4 of family 1. Mutant POFUT1 tran-
scripts were not detected. This mutation presumably leadsThe Amto nonsense-mediated decay of POFUT1 transcripts. Our
studies show that the mutation results in haploinsuffi-
ciency of POFUT1 with abnormal skin pigments; no
obvious anomaly was found in other organs and systems.
On the basis of this finding, we predict that POFUT1 can
maintain normal functions in most tissues and organs
under POFUT1 haploinsufficiency.
Melanocytes are well known to be responsible for the
pigmentation of animals. A series of studies have indicated
that the Notch signaling pathway plays an important role
in the regulation of melanocyte lineage development.31–33
Kumano et al. found that mice harboring a double hetero-
zygous deletion of Notch1 and Notch2 show gradual hair
graying after birth.34 Schouwey et al. also found a progres-
sive hair-graying phenotype induced by Notch1 and
Notch2 mutations but without changes in the pigmenta-
tion of the dermis and choroid.32 The researchers thus
speculated that both Notch1 and Notch2 contribute to
the maintenance of melanoblasts and melanocyte stem
cells and are essential for proper hair pigmentation.32
The DDD individuals in this study presented with pig-
mented anomalies on the skin of the neck, wrist, chest,
back, inguinal regions, and inner sides of the thighs but
had normal hair pigmentation. These results indicate
that haploinsufficiency of POFUT1 influences the Notch
signaling pathway more severely in skin than in hair in
humans. We also observed the abnormal distribution of
melanin in the 72 hpf zebrafish tail in the pofut1-MO
group. This finding is consistent with that of Aubin-Hou-
zelstein et al., who reported that melanoblasts and mela-
nocytes might be observed in ectopic locations in the
skin of cRBP-J-knockout mice.35 These results support the
hypothesis that disruption of the Notch signaling
pathway influences the migration of melanoblasts and
melanocytes.
A previous study showed that KRT5 would be another
pathogenic gene for DDD. Therefore, we evaluated the
expression of KRT5 in the pofut1-MO group and in shRNAerican Journal of Human Genetics 92, 895–903, June 6, 2013 901
POFUT1 HaCaT cells. We found that KRT5 expression was
lower in the shRNA POFUT1 cell model than in the con-
trols, and MO knockdown of pofut1 in zebrafish also
resulted in a corresponding decrease in the expressions
of krt5. Betz et al. speculated that keratins are crucial in
the organization of cell adhesion, melanosome uptake
into keratinocytes, organelle transport, and nuclear
anchorage.4 These results might explain why DDD indi-
viduals in this study presented with brown macules in
the skin.
In this study, we found that melanin synthesis was
strikingly affected after pofut1 knockdown in 48 hpf zebra-
fish. The melanin contents in the zebrafish tail at 48 hpf
and in both the tail and body axis at 72 hpf significantly
decreased in the pofut1-MO group compared with the
scMO and untreated control groups. It was speculated
that loss of function of pofut1 might influence the process
of melanin synthesis, so we evaluated the expression of
tyr and mitf. Both of them showed a remarkable reduction
in expression at the mRNA level, indicating that hypopig-
mented macules in DDD individuals most likely result
from an impairment of the ability to synthesize melanin
in the melanocytes with loss-of-function mutations in
pofut1. At 48 and 72 hpf in pofut1-MO zebrafish, tyrosi-
nase activities decreased by 33% and 45%, respectively,
whereas melanin protein contents decreased by 20%
and 25%, respectively. We also found that premelano-
somes were rarely observed by TEM in the proband of
family 1. Microphthalmia-associated transcription factor
(MITF) is regulated by multiple signals.36 The decrease of
mitf expression in zebrafish embryos indicates the rela-
tionship between mitf and the Notch pathway. MITF is
recognized as a master lineage regulator in melanocyte
development, involving various cellular processes such
as cell-cycle control, survival, motility, differentiation,
and pigmentation.37 Therefore, the mitf expression reduc-
tion resulting from pofut1 knockdown in zebrafish, of
course, influences the development of melanocytes. This
might explain why the melanocyte from individual III:8
in family 1 in TEM was small in size and lacked melano-
somes. These findings support the hypothesis that hap-
loinsufficiency of POFUT1 influences melanin synthesis
in melanocytes.Supplemental Data
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